DaBomb Protein Biotech Corp (6578) Fair Value & Analysis
Consumer Defensive · TW · Market cap 1.2B TWD
Fair value as of: Jul 12, 2026
From 2 valuation models · updated today
Fair value updated Jul 12, 2026 — revised from 75.63 TWD to 1.79 TWD (−97.6%) since Jun 24, 2026. Share price −0.9% over the past month.
Price vs Fair Value (12 months)
12‑month range 14.65 TWD – 25.55 TWD · fair‑value band 1.21 TWD – 2.37 TWD · the 16.45 TWD price screens above the 1.79 TWD fair value. As of Jul 12, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
DaBomb Protein Biotech Corp (6578) currently trades at 16.45 TWD, while our model-based Fair Value estimate is 1.79 TWD — implying the stock looks roughly 89.1% overvalued today. We read business quality at 33/100 (below-average quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, DaBomb Protein Biotech Corp generated revenue of 323M TWD at a net margin of -20.4%. Revenue grew 19.7% year over year. It earns a return on equity of -6.3%. Net debt stands at 38.0M TWD. Fundamentals as of Jul 12, 2026
Our scenario range runs from 1.21 TWD (bear case) to 2.37 TWD (bull case); at 16.45 TWD, the current price sits above that range. The share trades about 37% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -27% fair-value upside — at -89%, 6578 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 12, 2026. TTM = trailing twelve months.
About the company
DaBomb Protein Biotech Corp. manufactures and sells hydrolyzed soy protein in Vietnam, the Philippines, South Korea, Taiwan, and Asia. It offers nutrition and health care for aquatic products and economic animals; and pet health care products. The company also offers contract development and manufacturing organization services, including research and development, process design, and mass production services; product packaging solutions; and product formulation design and customized development services. It serves pet health food brands, pet nutrition product distribution channels, livestock feed enterprises, animal nutrition brands, and aquaculture industries. The company was formerly known as DaBomb Protein Corp. and changed its name to DaBomb Protein Biotech Corp. in October 2023. DaBomb Protein Biotech Corp. was incorporated in 2001 and is based in Tainan City, Taiwan.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
DaBomb Protein Biotech Corp reported revenue of 309M TWD in FY2025 versus 471M TWD in FY2021, a compound −10.0%/yr. Reported net income was −69.3M TWD in FY2025.
Is 6578 fairly valued? → Check now
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Jul 12, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé S.A NSRGF | $97.58 | $65.41 | -33% |
| Nestlé India Limited NESTLEIND | ₹1,438 | ₹362.37 | -75% |
| Grupo Bimbo, S.A. BIMBOA | 57.10 MXN | 83.34 MXN | +46% |
| Uni-President Enterprises Corp 1216 | 75.60 TWD | 55.53 TWD | -27% |
| Britannia Industries Limited BRITANNIA | ₹5,218 | ₹3,567 | -32% |
| Tata Consumer Products Limited TATACONSUM | ₹1,131 | ₹339.05 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,600 IDR | 14,500 IDR | +120% |
| Samyang Foods Co 003230 | 1,000,000 KRW | 1,066,643 KRW | +7% |
| PT Indofood Sukses Makmur Tbk INDF | 6,250 IDR | 22,853 IDR | +266% |
| Patanjali Foods Limited PATANJALI | ₹420.45 | ₹294.68 | -30% |
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is DaBomb Protein Biotech Corp (6578) undervalued?
What is the fair value of 6578?
What is the quality score of 6578?
What is the revenue of DaBomb Protein Biotech Corp (6578)?
What is the net profit margin of 6578?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full DaBomb Protein Biotech Corp analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.